136 related articles for article (PubMed ID: 35285219)
1. Cervical cancer screening among women with comorbidities: a cross-sectional examination of disparities from the Behavioral Risk Factor Surveillance System.
Austin J; Delgado P; Gatewood A; Enmeier M; Frantz B; Greiner B; Hartwell M
J Osteopath Med; 2022 Mar; 122(7):359-365. PubMed ID: 35285219
[TBL] [Abstract][Full Text] [Related]
2. National disparities in colorectal cancer screening in patients with comorbid conditions: an analysis of the Behavioral Risk Factor Surveillance System.
Greiner B; Gandhi R; Abrol R; Patel M; Hartwell M
J Osteopath Med; 2021 Apr; 121(7):657-662. PubMed ID: 33892528
[TBL] [Abstract][Full Text] [Related]
3. Exacerbating disparities?: Cervical cancer screening and HPV vaccination.
Silver MI; Kobrin S
Prev Med; 2020 Jan; 130():105902. PubMed ID: 31730943
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening and predictors of screening by diabetes status.
Miller EA; Pinsky PF
Cancer Causes Control; 2022 Oct; 33(10):1305-1312. PubMed ID: 35948701
[TBL] [Abstract][Full Text] [Related]
5. The Association of Cervical Cancer Screening With Disability Type Among U.S. Women (Aged 25-64 Years).
Orji AF; Gimm G; Desai A; Parekh T
Am J Prev Med; 2024 Jan; 66(1):83-93. PubMed ID: 37582416
[TBL] [Abstract][Full Text] [Related]
6. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
7. A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
Spagnoletti BRM; Bennett LR; Wahdi AE; Wilopo SA; Keenan CA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2429-2434. PubMed ID: 31450917
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
10. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
11. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
Elife; 2022 Jun; 11():. PubMed ID: 35762572
[TBL] [Abstract][Full Text] [Related]
12. Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women.
Cofie LE; Hirth JM; Wong R
Cancer Causes Control; 2018 Nov; 29(11):1105-1113. PubMed ID: 30353481
[TBL] [Abstract][Full Text] [Related]
13. [Implementation of National Cervical Cancer Screening Program in France].
Woronoff AS; Molinié F; Trétarre B
Bull Cancer; 2019 Mar; 106(3):253-261. PubMed ID: 30635113
[TBL] [Abstract][Full Text] [Related]
14. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
Zhang D; Advani S; Huchko M; Braithwaite D
BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
[TBL] [Abstract][Full Text] [Related]
15. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
16. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, attitude and practice towards cervical cancer prevention among mothers of girls aged between 9 and 14 years: a cross sectional survey in Zimbabwe.
Zibako P; Tsikai N; Manyame S; Ginindza TG
BMC Womens Health; 2021 Dec; 21(1):426. PubMed ID: 34930221
[TBL] [Abstract][Full Text] [Related]
19. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
[TBL] [Abstract][Full Text] [Related]
20. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]